We have detected that
JAVASCRIPT IS NOT ENABLED!
Much of the functionality of mirusbio.com requires Javascript to be enabled.
To avoid issues with site performance, please enable Javascript.
Font
Login
Register
Distributors
Shopping Cart - 0 Items, $0
View
|
Checkout
Research Products
TRANSFECTION
Trans
IT® Product Line
ELECTROPORATION
Ingenio® Product Line
LABELING
Label
IT® Product Line
IN VIVO
DELIVERY
Kits and Vectors
ACCESSORIES
General Accessory Products
Special Programs
Mirus Research Award Program
New Lab Set-up Program
Purchasing Information
Order Direct
Browse Products
International Distributors
Contact Mirus
Special Programs
Mirus Research Award Program
New Lab Set-up Program
Technical Resources
REAGENT AGENT
SM
Cell Transfection Database
Citation Database
Product Literature
Protocols
Material Safety Data Sheets (MSDS)
Frequently Asked Questions
Tech Spot
Tips from the Bench
Posters
Papers
Video Library
Contact Mirus
Search
Home
>
mRNA
>
Transmessenger Comparison
Share
Email
Print
Close
Click an icon below to share this page.
Product Details
TransMessenger Comparison
Electroporation Comparison
Request a FREE Sample
Trans
IT-mRNA Kit Benefits
Compare
Trans
IT®-mRNA Transfection Kit to TransMessenger™ Reagent:
More Efficient
Less Toxic
Easier to Use
Approximately 80% confluent cells were transfected with a capped and polyadenylated firefly luciferase mRNA using either the
Trans
IT®-mRNA Kit or TransMessenger™ Reagent (Qiagen). Approximately 18 hours post-transfection, cell confluency was determined, cells were harvested and then assayed for luciferase activity. Both TransMessenger sample luciferase activity (gray bars) and cell confluency (black) were scaled relative to the
Trans
IT-mRNA transfected samples (red bars) and presented as a percentage of the
Trans
IT-mRNA samples (set at 100%). In each experiment, the cells transfected with the
Trans
IT-mRNA Transfection Kit were approximately 100% confluent at the time of harvest.
Trans
IT®-mRNA Kit
TransMessenger™
Serum Compatibility
COMPATIBLE
Incompatible
Cell Wash Prior to Transfection
No
Yes
Media Change After Complex Addition
No
Yes
Cell Viability
High
Low
Prove It To Yourself
Request Your FREE
Trans
IT-mRNA Sample Today
-
MORE
Check out these publications citing
Trans
IT®-mRNA use:
Gonzalez et. al, (2007) Selection of an Optimal RNA Transfection Reagent and Comparison to Electroporation for the Delivery of Viral RNA.
J. Virological Methods
.
145
:14-21
(Direct comparison to DMRIE-C, TransMessenger™, and electroporation)
Meis and Meis, (2007) The New mScript™ mRNA Production System - Efficient mRNA Transcription, Capping and Tailing for High Yields of Active Protein.
EPICENTRE Forum
. 14(1):4-5
(Efficient mRNA delivery into HeLa, NIH3T3 and BDCM cell lines)
Duan and Jefcoate. (2007) The Predominant cAMP-stimulated 3.5 kb StAR mRNA Contains Specific Sequence Elements in the Extended 3'UTR that Confer High Basal Instability.
J. of Mol. Endocrin
.
38
:159-179
(mRNA transfection followed by mRNA stability measurements)
Products
Transfection
Electroporation
Labeling
In Vivo
Delivery
Accessories
Special Programs
Research Award Program
New Lab Set-up Program
Technical Resources
NEW! Reagent Agent
SM
Citations
Protocols
MSDS
Frequently Asked Questions
Tips from the Bench
Posters
Papers
Video Library
Company Overview
Corporate Profile
Employment
Directions
Events
News
Technologies
Contact Information
Contact Mirus
International Distributors
Purchasing
Ordering Information
Order Direct
Browse Products
View Cart
Tools
Site Search
Print this Page
Email this Page
Share This Page
Mirus Bio Homepage
Sitemap
© 2012 Mirus Bio LLC. All Rights Reserved. Legal ::
Terms and Conditions
|
Privacy Policy
|
Patents and Trademarks
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Processing...